Morus alba L. (Sangzhi) alkaloids reduce polycystic ovary syndrome by improving hypothalamic-pituitary-ovarian axis function
Phytomedicine · 2026
DOI: 10.1016/j.phymed.2026.158243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Phytomedicine, 2026. Verfasst von Yuanyuan Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Beijing Wehand-Bio Pharmaceutical Co. Ltd, Beijing, China; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China. Hauptthemen laut MEDLINE: Alkaloids, Hypothalamo-Hypophyseal System, Morus, Polycystic Ovary Syndrome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Science and Technology Planning Project, Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences, Tsinghua University.
Abstract (Originalsprache)
BACKGROUND: Polycystic ovary syndrome (PCOS) is a neuroendocrine-metabolic disorder with no approved drugs. Hypothalamic-pituitary-ovarian (HPO) axis dysfunction is core pathogenesis, and metabolic heterogeneity complicates treatment. Existing medications rarely ameliorate PCOS comprehensively. Sangzhi alkaloids (SZ-A), an extract from Morus alba L. twigs approved for type 2 diabetes in China, have not been systematically explored for PCOS. PURPOSE: To clarify the therapeutic effect and the mechanisms of SZ-A in PCOS. STUDY DESIGN: Animal studies, in vitro experiments and a placebo-controlled clinical trial. MATERIALS AND METHODS: In vivo: Obese/non-obese PCOS rats received oral SZ-A 67, 100, 150 mg/(kg·d) for 21 days (positive controls: Diane-35, metformin). In vitro: Granulosa cell apoptosis induced by dihydrotestosterone was treated with SZ-A 25, 50, 100, 200 μg/ml. CLINICAL: 6-month placebo-controlled trial (128 PCOS patients; oral SZ-A 300 mg/d, n = 88; placebo, n = 40). Multi-omics/Western blotting explored HPO pathways. RESULTS AND DISCUSSION: In rats, SZ-A (67 to 150 mg/(kg·d), 21 days) dose-dependently reduced androgens, regularized estrous cycles, and improved ovarian morphology. In vitro, SZ-A (25 to 200 μg/ml) protected granulosa cells from apoptosis. In patients, 6-month SZ-A (300 mg/d) lowered free androgen index and improved menstrual regularity versus placebo. Mechanistically, SZ-A inhibited hyperandrogenism-induced granulosa cell apoptosis and regulated GnRH secretion and downstream signaling pathways. CONCLUSION: SZ-A exerts therapeutic effects on PCOS by modulating HPO axis function through multiple pathways. TRIAL REGISTRATION: ChiCTR2200065097.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing Wehand-Bio Pharmaceutical Co. Ltd, Beijing, China; School of Pharmaceutical Sciences, Tsinghua University, Beijing, China.
- Provincial Clinical Key Specialty, Department of Endocrinology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, Jiangsu, China.
- Beijing Wehand-Bio Pharmaceutical Co. Ltd, Beijing, China.
- Municipal Clinical Key Specialty, Department of Endocrinology, The Affiliated Yixing Hospital of Jiangsu University, Yixing, Jiangsu, China.
- Provincial Clinical Key Specialty, Department of Endocrinology, The Second People's Hospital of Changzhou, The Third Affiliated Hospital of Nanjing Medical University, Changzhou, Jiangsu, China.
- Municipal Clinical Key Specialty, Department of Endocrinology, Jiangyin People's Hospital Affiliated to Nantong University, Jiangyin, Jiangsu, China.
Förderung
- Beijing Science and Technology Planning Project
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences
- Tsinghua University
- Beijing Natural Science Foundation
Zitieren
APA
Liu, Y., Wu, R., Li, H., Pu, D., Wang, X., Chen, S., Jiang, C., Hu, W., Wang, L., Ye, X., Huang, W., Wang, X., Hu, Y., Yuan, S., Han, Y., Ye, J., He, Q., Xu, L., & Liu, Y. (2026). Morus alba L. (Sangzhi) alkaloids reduce polycystic ovary syndrome by improving hypothalamic-pituitary-ovarian axis function. Phytomedicine. https://doi.org/10.1016/j.phymed.2026.158243
Vancouver
Liu Y, Wu R, Li H, Pu D, Wang X, Chen S, et al. Morus alba L. (Sangzhi) alkaloids reduce polycystic ovary syndrome by improving hypothalamic-pituitary-ovarian axis function. Phytomedicine. 2026. doi:10.1016/j.phymed.2026.158243
BibTeX
@article{Liu2026,
author = {Liu, Yuanyuan and Wu, Ruoyan and Li, Huijuan and Pu, Danfeng and Wang, Xingang and Chen, Shan and Jiang, Chenjie and Hu, Wangmin and Wang, Liyun and Ye, Xinhua and Huang, Wenlong and Wang, Xueqin and Hu, Yun and Yuan, Shiqin and Han, Yumeng and Ye, Jun and He, Qing and Xu, Lan and Liu, Yuling},
title = {Morus alba L. (Sangzhi) alkaloids reduce polycystic ovary syndrome by improving hypothalamic-pituitary-ovarian axis function},
journal = {Phytomedicine},
year = {2026},
doi = {10.1016/j.phymed.2026.158243}
}
EUVIMED